Community Clinical Research

Austin, Texas 78756

4 studies enrolling now · 27 studies all time

What they study most

Alzheimer's Disease, Bipolar Disorder, Bipolar Disorder Type I With Mania, Bipolar I Depression, Bipolar I Disorder, Blood Pressure, Chronic Schizophrenia, Cognitive Impairment Associated With Schizophrenia (CIAS), Depression, Depressive Disorder, Major, Mania, Schizophrenia

Studies at this site

• A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) — Recruiting now
• A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine — Recruiting now
• A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT — Recruiting now
• Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia — Completed
• An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
• A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia — Completed
• An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) — Completed
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) — Completed
• A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder — Completed
• Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia — Completed
• A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder — Completed
• Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) — Stopped early
• Post-Market Surveillance of Tobacco Products — Completed
• An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia — Completed
• A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole — Completed
• Safety and Tolerability Study of Drug to Treat Schizophrenia — Completed
• A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia — Completed
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia — Completed
• Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease — Completed
• Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia — Completed
• Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia — Completed